Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
04/2000
04/18/2000CA1340962C Arylhydrazones
04/13/2000WO2000019883A2 Compositions and methods of disease diagnosis and therapy
04/13/2000WO1999063824A3 Control of parasitic infestations in farmed and wild fish
04/13/2000CA2346765A1 Compositions and methods of disease diagnosis and therapy
04/12/2000EP0991662A1 Chlamyidia trachomatis specific peptides and their use in diagnostic assays
04/12/2000EP0991648A1 4-haloalkyl-3- heterocyclylpyridines and 4-haloalkyl -5-heterocyclylpyridines, method for the production thereof, agents containing the same and their use as pesticides
04/12/2000CN1249948A Changqing medicine powder resisting toxoplasmosis
04/12/2000CN1249933A Veterinary parasiticidal paste containing Albendazole and its preparation
04/06/2000WO2000018735A1 2-substituted heterocyclic sulfonamides
04/05/2000EP0670719B1 Combination of atovaquone with proguanil for the treatment of protozoal infections
04/04/2000US6045806 Babesia vaccine
03/2000
03/30/2000WO2000017387A1 Production and use of antimicrobial agents
03/30/2000WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000WO2000017233A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
03/30/2000WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000WO2000016804A1 METHODS OF TREATING IgE-ASSOCIATED DISORDERS AND COMPOSITIONS FOR USE THEREIN
03/30/2000WO2000016757A2 Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants
03/30/2000DE19843222A1 Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen Use of organophosphorus compounds for therapeutic and prophylactic treatment of infections
03/30/2000DE19837928A1 Treating summer eczema or malanders, especially in horses, using topical herbal composition derived from Equisetum plants, giving rapid cure of itching and chafing
03/30/2000CA2344867A1 Use of aminoalkylphosphonic acid derivatives for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants
03/30/2000CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000CA2343919A1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
03/30/2000CA2343360A1 Human cytoskeleton associated proteins
03/30/2000CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000CA2343052A1 Methods of treating ige-associated disorders and compositions for use therein
03/29/2000EP0988310A1 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
03/29/2000EP0988309A1 C-4''-substituted macrolide derivatives
03/29/2000EP0988308A1 9-oxime erythromycin derivatives
03/29/2000EP0988280A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties
03/29/2000EP0988054A1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
03/29/2000CN1249002A Component of bromelain
03/28/2000US6043238 2-Aminobenzazapine derivatives
03/28/2000US6043226 3,6-ketal and enol ether macrolide antibiotics
03/28/2000US6042825 A parasitic helminth asparaginase proteins; parasitic helminth asparaginase nucleic acid molecules that codes such asparaginase proteins
03/23/2000WO2000015770A2 Human serine/threonine protein kinases
03/23/2000WO2000015609A1 Azetidine derivatives, preparation and medicines containing them
03/23/2000WO2000015255A1 Vaccine against sexually transmitted diseases
03/23/2000WO2000015254A1 Immunogenic compositions and uses thereof
03/23/2000WO2000015240A1 Anionic or cationic dendrimer antimicrobial or antiparasitic compositions
03/23/2000WO2000015198A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000WO2000001347A3 Formulations for controlling human lice
03/23/2000CA2343760A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000CA2343578A1 Human serine/threonine protein kinases
03/22/2000EP0986564A1 6-SUBSTITUTED 1,2,4a,5a,8a,8b HEXAHYDRO- AND 1,2,3,4,4a,5a,8a,8b-OCTAHYDRO-6H-PYRROLO 3',4':4,5]FURO 3,2-b]PYRID-8(7H)-ON DERIVATIVES AND THEIR USE IN COMBATTING ENDOPARASITES
03/22/2000EP0986549A1 Desoxycyclodepsipeptides and their use for combatting endoparasites
03/22/2000EP0986390A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
03/22/2000EP0669831B1 Treatment of protozoal infection with bacitracin
03/16/2000WO2000014217A2 G-motif oligonucleotides and uses thereof
03/16/2000WO2000014079A1 Aza-cyclodepsipeptides and their use as antiparasitics
03/16/2000WO1999066953A3 Coccidiosis vaccine, method for the production thereof, and the use thereof
03/16/2000WO1999061471A3 Human transmembrane proteins
03/16/2000WO1999048501A9 Voacamine as anti-malarial agent and anti-malarial agent containing voacamine
03/16/2000CA2341338A1 G-motif oligonucleotides and uses thereof
03/15/2000EP0985040A1 Preparation of glycosylated tumor necrosis factor
03/15/2000EP0984955A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNF$g(a) LEVELS
03/15/2000EP0984783A1 Anthelmintic compositions
03/15/2000EP0797579B1 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity
03/15/2000CN1247530A Acrylonitrile compounds, process for their prodn. and pesticides containing them
03/15/2000CN1247066A Internally applied veterinary drug for treating pig's parasitosis
03/15/2000CN1050283C Gel-type cosmetic composite
03/14/2000US6036961 Immunogenic antigens of giardia cultures in bile
03/09/2000WO2000012519A1 Phosphoepoxides, method for making same and uses
03/09/2000WO2000012516A1 Phosphohalohydrins, method for making same and uses
03/09/2000WO2000012508A2 Pyrrolbenzodiazepines
03/09/2000WO2000012507A2 Pyrrolobenzodiazepines
03/09/2000WO2000012506A2 Collections of compounds
03/09/2000WO2000012498A1 Quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012108A1 Dry extract of henna, method for producing said extract and use of the same
03/09/2000WO2000012101A2 Use of selenium for treating patients suffering from systemic inflammatory response syndrome (sirs), and composition for implementing said treatment
03/09/2000DE19840320A1 Aza-Cyclodepsipeptide Aza-cyclodepsipeptides
03/09/2000DE19838809A1 Trockenextrakt aus der Hennapflanze, Verfahren zu dessen Herstellung und dessen Verwendung Dry extract of the henna plant, process for its preparation and its use
03/09/2000CA2341578A1 Phosphoepoxides, method for making same and uses
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0696287B1 Ureido derivatives of naphthalenephosphonic acids and process for their preparation
03/08/2000CN1246336A Medicine for treating chicken leucocyte protozoon
03/07/2000US6034134 1-Amino-alkylcyclohexane NMDA receptor antagonists
03/07/2000US6034129 Ionic polymers as anti-infective agents
03/07/2000US6034116 Mixtures of substituted benzimidazoles with polyether antibiotics or synthetic coccidiostats as agents for use against parasitic protozoa
03/07/2000US6034077 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/07/2000CA1340918C Macrolide compounds
03/02/2000WO2000011179A1 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM)
03/02/2000WO2000011170A1 14400 receptor, a g-protein coupled receptor
03/02/2000WO2000011023A2 Ring modified cyclic peptide analogs
03/02/2000WO2000010990A2 Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
03/02/2000WO2000010595A2 Medicaments for manipulating t-cell immune response
03/02/2000WO2000010582A2 Probiotic, lactic acid-producing bacteria and uses thereof
03/02/2000WO2000010532A1 Dinitroaniline liposomal formulations and processes for their preparation
03/02/2000WO1999057271A3 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
03/02/2000WO1999052547A9 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
03/02/2000CA2340676A1 Ring modified cyclic peptide analogs
03/02/2000CA2340457A1 14400 receptor, a g-protein coupled receptor
03/02/2000CA2306747A1 Dinitroaniline liposomal formulations and processes for their preparation
02/2000
02/29/2000US6031077 For prevention and treatment of heartworm infections; parasiticides; anthelmintics
02/29/2000US6030946 Reversible cysteine protease inhibitors
02/24/2000WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2
02/24/2000WO2000009665A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof
02/24/2000WO2000009653A2 Method of inhibiting cathepsin k
02/24/2000WO2000009541A1 nrdE
02/24/2000WO2000009500A2 Nematicidal pyrazoles
02/24/2000WO2000009150A2 Cytokine and cytokine receptor, agonist, antagonist and/or antibody combination for therapeutic use
1 ... 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 ... 218